These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Liver resection and transplantation for intrahepatic cholangiocarcinoma. Mazzaferro V; Gorgen A; Roayaie S; Droz Dit Busset M; Sapisochin G J Hepatol; 2020 Feb; 72(2):364-377. PubMed ID: 31954498 [TBL] [Abstract][Full Text] [Related]
27. [A long term survival case of advanced intrahepatic cholangiocarcinoma treated with multidisciplinary treatment]. Masuda T; Beppu T; Ishiko T; Mizumoto T; Hosaka S; Nakahara O; Hayashi H; Okabe H; Yamanaka T; Okabe K; Takamori H; Kanemitsu K; Hirota M; Baba H Gan To Kagaku Ryoho; 2006 Nov; 33(12):1944-6. PubMed ID: 17212154 [TBL] [Abstract][Full Text] [Related]
28. Locoregional options in the management of cholangiocarcinoma: single center experience. Baydoun H; Meirovich H; Maroun G; Coburn N; David E Ann Palliat Med; 2021 Feb; 10(2):1784-1791. PubMed ID: 33725764 [TBL] [Abstract][Full Text] [Related]
29. Future directions in the treatment of cholangiocarcinoma. Zhu AX Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434 [TBL] [Abstract][Full Text] [Related]
30. Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma. Seidensticker R; Ricke J; Seidensticker M Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):319-32. PubMed ID: 25966431 [TBL] [Abstract][Full Text] [Related]
31. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394 [TBL] [Abstract][Full Text] [Related]
32. [Intrahepatic cholangiocarcinoma - current perspectives and treatment algorithm]. Lurje G; Bednarsch J; Roderburg C; Trautwein C; Neumann UP Chirurg; 2018 Nov; 89(11):858-864. PubMed ID: 30182267 [TBL] [Abstract][Full Text] [Related]
33. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study. Goerg F; Zimmermann M; Bruners P; Neumann U; Luedde T; Kuhl C Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1709-1717. PubMed ID: 31578633 [TBL] [Abstract][Full Text] [Related]
34. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis. Al-Adra DP; Gill RS; Axford SJ; Shi X; Kneteman N; Liau SS Eur J Surg Oncol; 2015 Jan; 41(1):120-7. PubMed ID: 25449754 [TBL] [Abstract][Full Text] [Related]
35. Locoregional Therapy for Intrahepatic Cholangiocarcinoma. Owen M; Makary MS; Beal EW Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190311 [TBL] [Abstract][Full Text] [Related]
37. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598 [TBL] [Abstract][Full Text] [Related]
38. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. Moris D; Palta M; Kim C; Allen PJ; Morse MA; Lidsky ME CA Cancer J Clin; 2023 Mar; 73(2):198-222. PubMed ID: 36260350 [TBL] [Abstract][Full Text] [Related]
40. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma. Yuan P; Song J; Wang F; Zhu G; Chen B Invest New Drugs; 2022 Oct; 40(5):1125-1132. PubMed ID: 35793038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]